Mucosal Immunity
34.5K views | +21 today
Mucosal Immunity
The largest immune tissue in the body
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
February 16, 2023 3:56 AM
Scoop.it!

Home Page: Mucosal Immunology

Home Page: Mucosal Immunology | Mucosal Immunity | Scoop.it
Current IssueNovember 2022Volume 15Issue 6 Articles in Press Past Issues Submit article Articles in Press ReviewOpen AccessNecrotizing Enterocolitis in Premature Infants – A Defect in The Brakes? Evidence from Clinical and Animal StudiesSampath et al.Published online: February 15, 2023ArticleOpen AccessRhinovirus C Causes Heterogeneous Infection and Gene Expression in Airway Epithelial Cell SubsetsBasnet et al.Published online: February 14, 2023ArticleOpen AccessATG16L1 protects from IFN-γ-induced cell death in the small intestinal cryptFoerster et al.Published online: February 13, 2023Research ArticleOpen AccessIL-17 driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileumBrabec et al.Published online: February 2, 2023View All Collections Covid19 Emerging Leaders Helminth Immunology Mucosal Neuroimmunology Issue Highlights EditorialOpen ArchiveLessons from helminths: what worms have taught us about mucosal immunologyPerona-Wright et al.Published in issue: November, 2022EditorialOpen ArchiveA new age for (mucosal) NeuroImmunologyGerard EberlPublished in issue: November, 2022EditorialOpen ArchiveJohn Bienenstock ObituaryOgra et al.Published in issue: November, 2022CommentOpen AccessMicrobial antigen in human milk: a natural vaccine?van den Elsen et al.Published in issue: November, 2022 Most Read (Last 30 Days) ReviewOpen AccessInitiation of type 2 immunity at barrier surfacesMcDaniel et al.Published online: January 12, 2023Brief reportOpen AccessTissue-resident memory T cells trigger rapid exudation and local antibody accumulationRosato et al.Published online: January 16, 2023ArticleOpen AccessHigh-fat diet-induced resistance to helminth infection via alternative induction of type 2 immunityFunjika et al.Published online: January 20, 2023Review ArticleOpen AccessStromal regulation of the intestinal barrierSylvestre et al.Published online: January 25, 2023Research ArticleOpen AccessIL-17 driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileumBrabec et al.Published online: February 2, 2023Brief reportOpen AccessRegulation of angiotensin-converting enzyme 2 isoforms by type 2 inflammation and viral infection in human airway epitheliumStocker et al.Published online: January 12, 2023 About ## Impact Factor ## CiteScore ## 5-Year Impact Factor 3.98 days Time to Desk Reject 19 days Review Time Submit a Manuscript Most Cited (Previous 3 Years) Tweets by Mucosal Immunology SMI Features
No comment yet.
Scooped by Gilbert C FAURE
November 7, 2022 6:38 AM
Scoop.it!

Lessons from helminths: what worms have taught us about mucosal immunology

Merci Joel P.

une peu d'helminthes dans le site

https://www.scoop.it/topic/mucosal-immunity?q=helminths

 

 

No comment yet.
Scooped by Gilbert C FAURE
October 29, 2020 2:53 PM
Scoop.it!

Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue | Mucosal Immunology

Type 2 innate lymphoid cells (ILC2s) play a critical role early in the response to infection by helminths and in the development of allergic reactions. ILC2s are also involved in the physiologic regulation of adipose tissue and its metabolic response to cold shock.
No comment yet.
Scooped by Gilbert C FAURE
March 7, 2019 3:00 AM
Scoop.it!

The Intestinal Epithelium: Central Coordinator of Mucosal Immunity - The Microbiome

The Intestinal Epithelium: Central Coordinator of Mucosal Immunity - The Microbiome | Mucosal Immunity | Scoop.it
PubMed ID: 29716793 Allaire JM, Crowley SM, Law HT, Chang SY, Ko HJ, Vallance BA Trends Immunol. Sep 2018 COMMENT:  The intestinal mucosa, a single layer of cells, interacts with and, at the same time, is a barrier to luminal microbiota. The communication between microbes and intestinal epithelial cells (IECs) and how these cells interacts with the immune system is a crucial matter and the main topic of this review. This review illustrates the cellular and functional complexity of the intestinal mucosa: Various differentiated cell types are found within the gut epithelium, and each carries out unique and specialized functions. The distribution of these cell types is also different between the small and large bowel These cell types include: enterocytes, the most prominent cell type of the intestinal epithelium that is responsible for nutrient and water absorption, various secretory cells such as goblet cells that secrete mucins, enteroendocrine cells that secrete hormones, and Paneth cells that release antimicrobial factors to protect nearby stem cells at the base of small intestinal crypts. Finally, there are the chemosensory tuft cells which play a key role in defense against helminths, and M cells that are integral to the uptake and eventual presentation of luminal antigens to the immune system Regarding the well known and close relationship between microbiome and Intestinal mucosa, the authors indicate: The intestinal mucosa of germ- free mice is very thin, displaying reduced IEC proliferation as well as impaired production of mucins and other IEC-derived mediators. This thinning of the protective mucin layer makes germ-free mice highly susceptible to the direct toxic effects of the colitogenic agent dextran sodium sulfate (DSS), reinforcing the importance of gut microbes in promoting intestinal tissue protection and repair It seems that the presence of continous antigenic stimulus at the mucosa is an important factor to maintain a normal mucosa and that this depends on an intact innate MyD88 signalling pathway. Another important factor is the metabolic products of microbiota: Obligate anaerobes such as Clostridium clusters IV and IXa, Faecalibacterium prausnitzii, and Bacteroides thetaiotaomicron produce the majority of butyrate, a short-chain fatty acid (SCFA) that is found in the lumen of the colon and is mostly converted through fermentation of dietary fiber Luminal butyrate is largely consumed by differentiated colonocytes residing at the top of the crypts. The architecture of the intestinal crypt shields the stem cells located at the crypt base from this metabolite. Disruption/damage of the crypt architecture (as occurs in DSS colitis) exposes stem cells to higher butyrate levels, which in turn suppresses their proliferative capacity by inhibiting histone deacetylase (HDAC) enzymes and inducing transcription factor Forkhead box O3 (FoxO3) Other microbial metabolites have been found to modulate IEC function.  Lactate is an important energy source for small intestinal stem cells to sustain their proliferation and differentiation capacity. Acetate, an SCFA produced by Bifidobacterium, has also been shown to influence goblet cell differentiation. The presence of acetate-producing microbes as well as acetate itself increased goblet cell secretion of mucin, and also promoted the terminal decoration of mucin glycans with sialic acid, whereas the presence of an acetate-consumer (Fecalibacterium) reduced these effects. Germ-free mice, which lack these bacterial metabolites, displayed shorter Muc2 O-glycans, and this correlated with a decrease in the expression of their respective glycosyltransferase enzymes by IECs In summary: Bacterial metabolites within the intestinal environment are important in maintaining normal IEC physiology in the small intestine as well as in the colon. Crosstalk between the microbiota and IECs developed as a means to prevent IEC dysfunction, and recent studies have shown that disruption of this crosstalk can also lead to aberrant changes in the resident microbial populations, termed ‘dysbiosis’. There is substantial evidence that the resident intestinal microbiota works in concert with colonocytes to prevent enteric microbial dysbiosis such as that observed in IBD patients Butyrate is an important metabolic factor modulating intestinal immune cells functions: Butyrate can also epigenetically regulate gene expression through the inhibition of histone deacetylases. This appears to be the mode of action for the modulating influence of commensal microbiota on peripheral regulatory T cell (Treg) differentiation. In butyrate-treated naïve CD4+ T cells has been reported an increased histone H3 acetylation of Foxp3 at its promoter region and at the intronic enhancer ‘intragenic enhancer elements conserved noncoding DNA sequence 1’ (CNS1) and CNS3 . This increased acetylation of Foxp3 resulted in increased gene expression. CNS1-deficient mice were unresponsive to the pres- ence of butyrate and did not induce FOXP3 expression in naïve CD4+ T cells Overall, butyrate influences the balance between intestinal pro- and anti-inflammatory mechanisms Colonization resistance is an important feature of a healthy microbiome: Invading microbes must compete for limited space and nutrients against entrenched microbiota–host symbiotic relationships as well as resist against potent antimicrobial molecules produced by some resident gut microbes. For example, Bacteroides thuringiensis, a bacterium found in human feces, produces a narrow-spectrum bacteriocin that is highly potent against the nosocomial pathogen Clostridium difficile. This bacteriocin, named thucin CD, is a two-component antimicrobial that acts synergistically to disrupt the cell membrane of its target Innate Immune System molecules and IECs: Situated at the interface between the luminal microbiota and the underlying immune system, the intestinal epithelium plays a crucial role in the detection of microbes under homeostatic as well as pathologic conditions. IECs express a variety of innate receptors that detect microbes and endogenous danger signals, including the TLRs Enterocytes are known to express TLR2, TLR3, TLR4, TLR5, and TLR9 The polarized nature of IECs facilitates the anatomical distribution of TLRs, segregating the majority to the basolateral membrane, while TLR2 and TLR9 are also expressed at the apical surface Once activated at the basolateral membrane, TLR signaling initiates a signaling cascade cumulating in the nuclear translocation of NF-kB. This leads to the expression and secretion of various cytokines and chemokines, including TNF-a, IL-6, IL-8, IL-18, and CCL20, which signal and prime underlying immune cells By contrast, apical stimulation of TLR9 results in a net immune inhibitory effect through the stabilization of IkB, demonstrating the unique ability of IECs to differentially respond to microbial signals using the same receptors but at varying spatiotemporal positions TLRs expressed by IECs play a key role in recognizing nearby microbes and their products, the responses they elicit are primarily aimed at keeping microbes at a distance (mucin secretion and antimicrobial production) or recruiting immune cells (via chemokines) to the site of infection. Upon direct invasion of IECs by intracellular pathogens, a more vigorous means of host defense is triggered, by which enterocytes can physically expel themselves from the intestinal epithelial lining while still maintaining mucosal barrier function. This process prevents intracellular pathogens from breaching the epithelial barrier, and instead they are extruded into the fecal stream, along with the sloughed enterocyte. This expulsion is independent from the homeostatic process of continuous enterocyte renewal. and instead involves activation of the inflammatory caspases (caspase-1, -4, and -11) as well as caspase-8 Not only enterocytes and colonocytes but also enterochromaffin cells make a crosstalk with microbiota: Some members of the intestinal microbiota, particularly spore-forming Clostridia spp., can stimulate colonic entero- chromaffin cells to upregulate their production of the neurotransmitter 5-HT In the context of an enteric infection, a limited number of studies suggest that production of 5-HT can aid in preventing incursion by microbial (S. Typhimurium) and helminthic (Trichuris muris) pathogens, possibly through the modulation of enterocyte function (such as antimicrobial peptide secretion and IL-13 receptor a1 signaling). Recent findings revealed that L cells, another type of enteroendocrine cell, can secrete glucagon-like peptide (GLP) 1 in a TLR4-dependent manner upon exposure to bacteria-derived LPS during gut injury or chemical-induced colitis in mice And also Paneth cells with a potential very interesting relationship with Crohn’s disease: Paneth cells, found specifically in the small intestine, have received the most attention based on their specialized role in secreting large granules filled with antimicrobial peptides and enzymes such as a-defensins, RegIIIg, sPLA2, and lysozyme. The baseline release of these antimicrobials is thought to promote normal microbial composition within the intestinal lumen.  This theory is based on recent studies linking the presence of structurally and functionally abnormal Paneth cells in Crohn’s disease (CD) patients to the development of microbial dysbiosis within the ileum. Significant reductions in barrier promoting microbes such as Faecalibacterium prausnitzii were also observed, emphasizing the crucial role played by Paneth cells in regulating intestinal microbial homeostasis. In this regard, single-nucleotide polymorphisms (SNPs) in several IBD-associated genes such as NOD2, XBP1, ATG16L1, and IRGM have been linked to Paneth cell dysfunction in IBD patients. These Paneth cell abnormalities include structurally irregular granules as well as impaired autophagic secretory pathways and failure in autophagy-based removal of damaged organelles. Two different hypomorphic Atg16l mouse models suggest that ATG16L1 controls the shape and distribution of Paneth cell granules as well as their production of lysozyme. Interestingly, biopsies of CD patients possessing the relevant ATG16L1 polymorphisms, but with quiescent disease, show an increased incidence of intestinal colonization by the microbial pathobiont adherent-invasive Escherichia coli (AIEC). This suggests that defects in autophagy, presumably within Paneth cells, may increase the susceptibility of CD patients to colonization or infection by specific microbes such as AIEC, and potentially predispose the patients to disease progression that requires intestinal surgery Although innate signaling plays an important role in the function of Paneth cells, presumably there are other pathways involved in controlling their ability to release their secretory granules, such as would occur in response to an infection of the small intestine. Interestingly, both in vivo and in vitro studies have demonstrated that exposure to IFN-g causes rapid and complete degranulation of Paneth cells, accompanied by their luminal extrusion and apoptosis And Globet cells: Intestinal goblet cells are best known for their production and secretion of the glycosylated mucin protein Muc2 which forms the protective mucus barrier atop the intestinal epithelium.  In its absence, Muc2-/- mice suffer exaggerated bacterial contact with their colonic epithelium, provoking inflammatory responses that eventually develop into spontaneous colitis. While Muc2 is normally released at a baseline level, in response to noxious luminal stimuli goblet cells undergo compound exocytosis, thereby releasing all of their mucin granules and other contents into the lumen to protect the epithelial barrier from direct contact with these threats. Intestinal goblet cells exposed to bacterial products or cytokines such IL-22 and IFN-g undergo this compound exocytosis IECs communicate with the Immune System: Early in the 1990s enterocytes were found to secrete an array of chemokines and cytokines, particularly in response to direct contact with bacteria or their products. Many of these secreted molecules are known to recruit and/or activate neutrophils, macrophages, dendritic cells, and T cells. The ability of enterocytes, and presumably other IEC types, to direct these cells and the local immune response is thought to be key to the resolution of infections that have crossed the gut barriers, as well as to the promotion mucosal repair following intestinal damage. Tuft cells: Renewed interest in tuft cells has been prompted recently owing to their newly discovered roles in detecting helminth parasites and as drivers of ILC2 expansion. Luminal helminths such as T. muris can be sensed by tuft cells through their GTP-binding protein a-gustducin that activates the non-selective cation channel transient receptor potential melastatin-like subtype 5 channel (Trpm5). Interestingly, in the oral cavity Trpm5 is responsible for the transduction of bitter, sweet, and umami tastes, and when colonic tuft cells are subjected to the bitter substrate denatonium this correlated with a sharp increase in intracellular calcium. This may denote chemosensors as a new class of pathogen recognition receptors if tuft cells are truly responding to chemicals secreted by invading parasites. Tuft cells constitutively secrete IL-25 to maintain ILC2 homeostasis, but upon recognizing helminths they increased their secretion of IL-25, which directly acts on ILC2 cells to release IL-13 This in turns feeds forward, with IL- 13 acting on epithelial progenitors in an IL-13Ra1/IL-4aR-dependent manner to promote tuft cell and goblet cell hyperplasia, cumulating in a dramatic increase in bulk mucin release that drives the expulsion of the parasite from the intestinal tract In summary, this review highlights the importance and complexity of IECs for the microbiome, defense against pathogens and local modulation of the Immune System  Contributor Eduardo Pareja
No comment yet.
Scooped by Gilbert C FAURE
January 7, 2018 11:14 AM
Scoop.it!

S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense

S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense | Mucosal Immunity | Scoop.it
Group 2 innate lymphoid cells (ILC2s) are a population of immune cells that play important roles in tissue homeostasis and barrier immunity to helminths. Recent work has suggested that ILC2s are primarily long-term residents of tissues that do not readily recirculate. Huang et al. now demonstrate, however, that these findings do not necessarily hold true for the interleukin-25 (IL-25)–responsive KLRG1hi “inflammatory” ILC2 (iILC2) subset (see the Perspective by Mjösberg and Rao). In response to exogenous IL-25 or helminth infection, iILC2 precursors in the small intestinal lamina propria proliferate and alter their expression of sphingosine 1-phosphate (S1P) receptors. They then traffic to both lymphatic and nonlymphatic organs in a partly S1P-dependent manner, participating in vital anti-helminth and tissue repair responses.

Science , this issue p. [114][1]; see also p. [36][2]

[1]: /lookup/doi/10.1126/science.aam5809
[2]: /lookup/doi/10.1126/science.aar4301
No comment yet.
Scooped by Gilbert C FAURE
December 5, 2017 2:18 AM
Scoop.it!

Frontiers | Interactions between Innate Lymphoid Cells and Cells of the Innate and Adaptive Immune System | Immunology

Frontiers | Interactions between Innate Lymphoid Cells and Cells of the Innate and Adaptive Immune System | Immunology | Mucosal Immunity | Scoop.it
Type 2 innate lymphoid cells (ILC2s) are a major source of cytokines which are also produced by Th2 cells and several cell types of the innate immune system. Work over the past few years indicates that ILC2s play a central role in regulating type 2 immune responses against allergens and helminths. ILC2s can interact with a variety of cells types of the innate and adaptive immune system by cell-cell contacts or by communication via soluble factors. In this review we provide an overview about recent advances in our understanding how ILC2s orchestrate type 2 immune responses with focus on direct interactions between ILC2s and other cells of the immune system.
No comment yet.
Scooped by Gilbert C FAURE
March 23, 2016 2:46 PM
Scoop.it!

Mucosal Immunology - Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths

Mucosal Immunology - Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths | Mucosal Immunity | Scoop.it
Mucosal Immunology is the official publication of the Society of Mucosal Immunology (SMI). It aims to provide a forum for both basic and clinical scientists to discuss all aspects of immunity and inflammation involving mucosal tissues.
No comment yet.
Scooped by Gilbert C FAURE
August 27, 2015 9:20 AM
Scoop.it!

Mucosal Immunology - Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths

Mucosal Immunology - Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths | Mucosal Immunity | Scoop.it
These findings highlight the overarching importance of the early Treg response to infection and the non-linear association between inflammation and the prevailing Treg frequency.
No comment yet.
Scooped by Gilbert C FAURE
September 3, 2013 10:47 AM
Scoop.it!

PLOS Pathogens: IL-1β Suppresses Innate IL-25 and IL-33 Production and Maintains Helminth Chronicity

PLOS Pathogens: IL-1β Suppresses Innate IL-25 and IL-33 Production and Maintains Helminth Chronicity | Mucosal Immunity | Scoop.it
From molecules to physiology (RT @INBIONET: Just published work by INBIONET PI Nicola Harris on helminths modulation of mucosal immunology http://t.co/4igWEdsMbr)...
No comment yet.
Scooped by Gilbert C FAURE
December 15, 2022 3:27 AM
Scoop.it!

The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF) | Mucosal Immunology

The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF) | Mucosal Immunology | Mucosal Immunity | Scoop.it
Macrophage migration inhibitory factor (MIF) is a key innate immune mediator with chemokine- and cytokine-like properties in the inflammatory pathway. While its actions on macrophages are well-studied, its effects on other cell types are less understood. Here we report that MIF is required for expansion of intestinal tuft cells during infection with the helminth Nippostrongylus brasiliensis. MIF-deficient mice show defective innate responses following infection, lacking intestinal epithelial tuft cell hyperplasia or upregulation of goblet cell RELMβ, and fail to expand eosinophil, type 2 innate lymphoid cell (ILC2) and macrophage (M2) populations. Similar effects were observed in MIF-sufficient wild-type mice given the MIF inhibitor 4-IPP. MIF had no direct effect on epithelial cells in organoid cultures, and MIF-deficient intestinal stem cells could generate tuft cells in vitro in the presence of type 2 cytokines. In vivo the lack of MIF could be fully compensated by administration of IL-25, restoring tuft cell differentiation and goblet cell expression of RELM-β, demonstrating its requirement upstream of the ILC2-tuft cell circuit. Both ILC2s and macrophages expressed the MIF receptor CXCR4, indicating that MIF may act as an essential co-factor on both cell types to activate responses to IL-25 in helminth infection.
No comment yet.
Scooped by Gilbert C FAURE
February 28, 2021 1:46 PM
Scoop.it!

Association between physical activity and changes in intestinal microbiota composition: A systematic review

Association between physical activity and changes in intestinal microbiota composition: A systematic review | Mucosal Immunity | Scoop.it
Introduction The intestinal microbiota comprises bacteria, fungi, archaea, protists, helminths and viruses that symbiotically inhabit the digestive system. To date, research has provided limited data on the possible association between an active lifestyle and a healthy composition of human...
No comment yet.
Suggested by Société Francaise d'Immunologie
May 13, 2019 2:43 PM
Scoop.it!

The Role of Mast Cells in the Defence against Pathogens

The Role of Mast Cells in the Defence against Pathogens | Mucosal Immunity | Scoop.it
PLoS Pathog. 2012 Apr; 8(4): e1002619. Published online 2012 Apr 26. doi: 10.1371/journal.ppat.1002619 PMCID: PMC3343118 PMID: 22577358 The Role of Mast Cells in the Defence against Pathogens Joseph Heitman, Editor This article has been cited by other articles in PMC. Although mast cells are best known for their role in mediating allergic diseases, recent studies have highlighted the important role that these cells play in the protection against infection with a variety of organisms. What Are Mast Cells? Mast cells are leukocytes that are derived from haematopoietic progenitor cells. They circulate in the blood in an immature form before migrating to vascularised tissues, where they undergo final differentiation and maturation with the help of stem-cell factor and other cytokines secreted by endothelial cells and fibroblasts. Mast cells are found in most tissues of the body, particularly in locations that are in close contact with the external environment, such as skin, airways, and intestines. They are, therefore, ideally placed to participate in the early recognition of pathogens. Activation of mast cells results in the release of a variety of soluble factors. Within seconds of stimulation, mast cells can undergo degranulation, rapidly releasing pre-formed mediators present within cytoplasmic granules, including histamine, the proteases tryptase and chymase, and pre-formed tumour necrosis factor-alpha (TNF-α; reviewed in [1], [2]). Shortly after the initiation of degranulation, mast cells can produce lipid-derived eicosanoids such as prostaglandin D2 and leukotriene C4 (LTC4). Finally, over the course of hours, the transcriptional up-regulation of cytokines and chemokines, including TNF-α and interleukin-4, can be observed. Importantly, each of these responses may occur alone or in combination depending on the stimulus. Because of their location, their plasticity, and the various mediators they produce, mast cells are important immune effector and modulatory cells that help link innate and adaptive immunity in the fight against pathogens. How Do Pathogens Activate Mast Cells? The best studied mechanism for the activation of mast cells is via stimulation of the high-affinity immunoglobulin E (IgE) receptor FcεRI (reviewed in [3]). Binding of an antigen by FcεRI-bound specific IgE leads to FcεRI clustering, which in turn induces downstream signalling events and ultimately the release of mediators. Although initially described in the context of allergy, this response is important in the response to parasites, including nematodes and malaria. Mast cells also express Fc receptors that bind IgG and a variety of complement receptors, and therefore can potentially respond to opsonised organisms. The role of these receptors in mast cell activation during infection remains less well defined. As with other leukocytes, mast cells can also be activated by directly interacting with pathogens through pattern recognition receptors (PRRs), including the Toll-like receptors (TLRs), Nod-like receptors, C-type lectins such as Dectin-1, and the glycosylphosphatidylinositol-anchored protein CD48. Selective engagement of PRRs is also an important mechanism in governing the type of mast cell response. For example, while peptidoglycan stimulation of bone marrow-derived mast cells via TLR2 leads to both cytokine release and degranulation, lipopolysaccharide (LPS) stimulation through TLR4 results in cytokine release alone [4]. Furthermore, Dectin-1 binding of fungal β-glucan induces the release of LTC4 by mast cells [5] while CD48 binds to the Escherichia coli adhesin FimH, and induces the release of TNF-α [6]. How Do Mast Cells Contribute to Host Defence? Mast cells are well placed to serve as immune sentinel cells to both respond directly to pathogens and send signals to other tissues to modulate both innate and adaptive immune responses (Figure 1). Mast cells can participate in direct killing of organisms by phagocytosis and reactive oxygen species production [7], and can produce antimicrobial peptides, such as cathelicidins, both constitutively and in response to LPS or lipoteichoic acid exposure [8]. These peptides were found to mediate killing of Group A streptococci (GAS) in vitro and in vivo [8]. Additionally, similar to neutrophils, mast cells have been found to produce extracellular traps that encompass and kill organisms, such as GAS, in vitro [9]. Although these microbicidal responses may be important in some infections, the relatively small number of mast cells in tissues suggests that indirect effects of mast cells in coordinating host innate and adaptive responses may be more important in the balance of host defence. Future studies defining the relative contributions of direct and indirect antimicrobial effects are required. Mast cells can modulate host innate immune responses through the release of granular and secreted mediators (reviewed in [1], [2]). The release of histamine and other vasoactive mediators increases vascular permeability and local blood flow, and can act on smooth muscle to increase the expulsion of mucosal parasites. In addition, histamine enhances epithelial cell mucus production, which may aid in pathogen immobilisation and cytoprotection. Finally, mast cell production of chemotactic factors can enhance the recruitment of multiple inflammatory cells including eosinophils (eotaxin), natural killer (NK) cells (IL-8), and neutrophils (IL-8 and TNF-α). Mast cell products have also been implicated in the regulation of adaptive immune responses (reviewed in [1], [2]). Mast cell–derived cytokines and chemokines can enhance the migration of dendritic cells (DCs; TNF-α and CCL20) and effector T cells (CXCL10/IP10 and CCL5/RANTES) to the site of infection and to draining lymph nodes. Mast cells can also function directly as antigen-presenting cells, particularly for CD8+ T cells. In addition, mast cell products can enhance the maturation of immature DCs, and up-regulate antigen presentation and the expression of co-stimulatory molecules. Interestingly, while mast cell–derived histamine was observed to favour the polarization of naive T cells towards a Th2 phenotype by reducing DC production of IL-12 and increasing IL-10 secretion in response to LPS [10], direct contact with mast cells can prime DCs to promote Th17 and Th1 polarization in vitro [11]. Although these findings require confirmation in vivo, they suggest that mast cells may act to promote the development of different immune responses depending on environmental and other cues. Importantly, while mast cell responses may act to increase host defence locally at the site of infection, it is also possible that mast cell–mediated enhancement of inflammation could induce damage of host tissues and worsen outcome during some infections. In support of this hypothesis, a recent study observed that while intraperitoneal mast cells were found to be protective in a model of experimental polymicrobial intra-abdominal sepsis, extraperitoneal mast cells in the same system produced pro-inflammatory IL-6, which was associated with increased mortality [12]. This increase in mortality was associated with increased circulating histamine, suggesting that severe sepsis led to the induction of systemic mast cell degranulation distal to the site of infection, and subsequent overproduction of pro-inflammatory mediators. Mast Cells Have Been Implicated in the Defence against Which Pathogens? Recent studies have demonstrated that mast cells play a protective role against many pathogens. Significant advances have been made using mast cell–deficient mice, although the specific mechanisms by which mast cells inhibit most pathogens remain relatively undefined. The first evidence supporting the protective role of mast cells against pathogens came from studies of parasitic infections including helminths, nematodes, and protozoa (reviewed in [1], [2]). Experiments using mast cell–deficient mice have found that mast cells accelerate hookworm expulsion from the gut in association with the production of mast cell protease 2. Similar studies in models of Trichinella spiralis and Strongyloides infection have found that mast cells mediate gut expulsion of nematodes and limit the parasite tissue burden. Moreover, mast cell–deficient mice develop increased parasite burden and larger lesions during infection with Leishmania major in association with a reduction in inflammation and IL-12 production at the site of infection. Finally, a critical role for mast cell–derived TNF in limiting parasitaemia in a murine model of malaria has been demonstrated by reconstituting mast cell–deficient mice with mast cells derived from wild-type and TNF-deficient mice [13]. More recently, the contributions of mast cells to antibacterial immunity have also been established, particularly with respect to gram-negative bacteria (reviewed in [1], [2]). Mast cells have been found to attenuate experimental pulmonary infection with Klebsiella pneumoniae [14] and Mycoplasma pneumoniae; Pseudomonas aeruginosa and GAS skin infection; Haemophilus influenzae otitis media; and E. coli peritoneal and urinary infections, as well as polymicrobial intra-abdominal sepsis [15]. Evidence that mast cells mediate antiviral immunity is more limited. Mast cell activation by synthetic viral dsRNA led to the recruitment of CD8+ T cells to the site of infection that was absent in mast cell–deficient mice [16]. Dengue infected mast cell–deficient mice had an increased viral burden within draining lymph nodes due to the lack of recruitment of NK and NK T cells to the site of infection [17]. Conversely, however, in HIV infection, mast cells may serve as a viral reservoir during latent infection [18]. The role of mast cells in the pathogenesis of fungal infection is even less well understood. In vitro studies have found that mast cells released LTC4 in response to zymosan, a Saccharomyces cerevisiae cell wall preparation [5]. A single study examining the interaction of live fungi and mast cells in vitro found that Aspergillus fumigatus hyphae induced degranulation of mast cells via an IgE-independent mechanism [19]. Extending these studies in vivo will be critical for understanding the role of mast cells in fungal infections, as there may be important differences between the role of mast cells in the defence against fungi and other eukaryotic pathogens such as parasites. For example, while the induction of a mast cell–associated Th2 response is classically protective in parasitic infection, a Th2 response is usually detrimental during fungal infection [20]. Could Enhancing Mast Cell Function Protect against Infection? In allergic diseases, mast cells are seen as harmful triggers of chronic inflammation, and mast cell stabilizing agents and inhibitors are frequently used as treatment. However, emerging data suggest that mast cells are crucial in protecting the host from many infections. Although substantial effort has been directed towards defining and reversing the effects of corticosteroids and other immunosuppressive agents on neutrophil, macrophage, and dendritic cell function, similar studies are lacking for mast cells. Failure of mast cells to function as immune sentinels early in infection may play an important role in mediating susceptibility to infection in patients receiving corticosteroids or other mast cell–suppressing agents. Future studies will be required to understand the effects of these agents on specific aspects of mast cell function and subsequent susceptibility to specific infections. New strategies focused on enhancing the beneficial roles of mast cells may facilitate the early response to pathogens when the microbial burden is low. Footnotes The authors have declared that no competing interests exist. This work was supported by an operating grant from the Canadian Cystic Fibrosis Foundation to DCS and federal funds from the National Institute of Allergy and Infectious Diseases, under contract no. N01-AI-30041 1. DCS is supported by Chercheur-Clinicien Award from the Fonds de Recherche du Québec -Santé. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. References 1. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol. 2010;10:440–452. [PMC free article] [PubMed] [Google Scholar] 2. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Curr Opin Immunol. 2007;19:31–38. [PubMed] [Google Scholar] 3. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol. 2006;6:218–230. [PubMed] [Google Scholar] 4. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, et al. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol. 2001;167:2250–2256. [PubMed] [Google Scholar] 5. Olynych TJ, Jakeman DL, Marshall JS. Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. J Allergy Clin Immunol. 2006;118:837–843. [PubMed] [Google Scholar] 6. Malaviya R, Gao Z, Thankavel K, van der Merwe PA, Abraham SN. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci U S A. 1999;96:8110–8115. [PMC free article] [PubMed] [Google Scholar] 7. Malaviya R, Ross EA, MacGregor JI, Ikeda T, Little JR, et al. Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol. 1994;152:1907–1914. [PubMed] [Google Scholar] 8. Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol. 2003;170:2274–2278. [PubMed] [Google Scholar] 9. von Kockritz-Blickwede M, Goldmann O, Thulin P, Heinemann K, Norrby-Teglund A, et al. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood. 2008;111:3070–3080. [PubMed] [Google Scholar] 10. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest. 2001;108:1865–1873. [PMC free article] [PubMed] [Google Scholar] 11. Dudeck A, Suender CA, Kostka SL, von Stebut E, Maurer M. Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function. Eur J Immunol. 2011;41:1883–1893. [PubMed] [Google Scholar] 12. Seeley EJ, Sutherland RE, Kim SS, Wolters PJ. Systemic mast cell degranulation increases mortality during polymicrobial septic peritonitis in mice. J Leukoc Biol. 2011;90:591–597. [PMC free article] [PubMed] [Google Scholar] 13. Furuta T, Kikuchi T, Iwakura Y, Watanabe N. Protective roles of mast cells and mast cell-derived TNF in murine malaria. J Immunol. 2006;177:3294–3302. [PubMed] [Google Scholar] 14. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 1996;381:77–80. [PubMed] [Google Scholar] 15. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 1996;381:75–77. [PubMed] [Google Scholar] 16. Orinska Z, Bulanova E, Budagian V, Metz M, Maurer M, et al. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood. 2005;106:978–987. [PubMed] [Google Scholar] 17. St John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, et al. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A. 2011;108:9190–9195. [PMC free article] [PubMed] [Google Scholar] 18. Sundstrom JB, Ellis JE, Hair GA, Kirshenbaum AS, Metcalfe DD, et al. Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood. 2007;109:5293–5300. [PMC free article] [PubMed] [Google Scholar] 19. Urb M, Pouliot P, Gravelat FN, Olivier M, Sheppard DC. Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. J Infect Dis. 2009;200:464–472. [PubMed] [Google Scholar] 20. Cenci E, Perito S, Enssle KH, Mosci P, Latge JP, et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun. 1997;65:564–570. [PMC free article] [PubMed] [Google Scholar] Articles from PLoS Pathogens are provided here courtesy of Public Library of Science
No comment yet.
Scooped by Gilbert C FAURE
December 1, 2018 4:42 AM
Scoop.it!

Basophils are dispensable for the establishment of protective adaptive immunity against primary and challenge infection with the intestinal helminth parasite Strongyloides ratti

Basophils are dispensable for the establishment of protective adaptive immunity against primary and challenge infection with the intestinal helminth parasite Strongyloides ratti | Mucosal Immunity | Scoop.it
Author summary Helminths are large multicellular parasites that infect approximately every third person. Infections are controlled by a concerted action of innate and adaptive immune responses. Basophils and mast cells are innate effector cells with overlapping functions that have recently been...
No comment yet.
Scooped by Gilbert C FAURE
January 6, 2018 11:12 AM
Scoop.it!

S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense

S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense | Mucosal Immunity | Scoop.it
Group 2 innate lymphoid cells (ILC2s) are a population of immune cells that play important roles in tissue homeostasis and barrier immunity to helminths. Recent work has suggested that ILC2s are primarily long-term residents of tissues that do not readily recirculate. Huang et al. now demonstrate, however, that these findings do not necessarily hold true for the interleukin-25 (IL-25)–responsive KLRG1hi “inflammatory” ILC2 (iILC2) subset (see the Perspective by Mjösberg and Rao). In response to exogenous IL-25 or helminth infection, iILC2 precursors in the small intestinal lamina propria proliferate and alter their expression of sphingosine 1-phosphate (S1P) receptors. They then traffic to both lymphatic and nonlymphatic organs in a partly S1P-dependent manner, participating in vital anti-helminth and tissue repair responses.

Science , this issue p. [114][1]; see also p. [36][2]

[1]: /lookup/doi/10.1126/science.aam5809
[2]: /lookup/doi/10.1126/science.aar4301
Gilbert C FAURE's insight:
Abstract Innate lymphoid cells (ILCs) are innate counterparts of adaptive T lymphocytes, contributing to host defense, tissue repair, metabolic homeostasis, and inflammatory diseases. ILCs have been considered to be tissue-resident cells, but whether ILCs move between tissue sites during infection has been unclear. We show here that interleukin-25– or helminth-induced inflammatory ILC2s are circulating cells that arise from resting ILC2s residing in intestinal lamina propria. They migrate to diverse tissues based on sphingosine 1-phosphate (S1P)–mediated chemotaxis that promotes lymphatic entry, blood circulation, and accumulation in peripheral sites, including the lung, where they contribute to anti-helminth defense and tissue repair. This ILC2 expansion and migration is a behavioral parallel to the antigen-driven proliferation and migration of adaptive lymphocytes to effector sites and indicates that ILCs complement adaptive immunity by providing both local and distant tissue protection during infection.
No comment yet.
Scooped by Gilbert C FAURE
November 18, 2016 9:04 AM
Scoop.it!

The common mouse protozoa Tritrichomonas muris alters mucosal T cell homeostasis and colitis susceptibility

The common mouse protozoa Tritrichomonas muris alters mucosal T cell homeostasis and colitis susceptibility | Mucosal Immunity | Scoop.it
The mammalian gastrointestinal tract hosts a diverse community of microbes including bacteria, fungi, protozoa, helminths, and viruses. Through coevolution, mammals and these microbes have developed a symbiosis that is sustained through the host’s continuous sensing of microbial factors and the generation of a tolerant or pro-inflammatory response. While analyzing T cell–driven colitis in nonlittermate mouse strains, we serendipitously identified that a nongenetic transmissible factor dramatically increased disease susceptibility. We identified the protozoan Tritrichomonas muris as the disease-exacerbating element. Furthermore, experimental colonization with T. muris induced an elevated Th1 response in the cecum of naive wild-type mice and accelerated colitis in Rag1 −/− mice after T cell transfer. Overall, we describe a novel cross-kingdom interaction within the murine gut that alters immune cell homeostasis and disease susceptibility. This example of unpredicted microbial priming of the immune response highlights the importance of studying trans-kingdom interactions and serves as a stark reminder of the importance of using littermate controls in all mouse research.
No comment yet.
Scooped by Gilbert C FAURE
January 18, 2016 1:14 PM
Scoop.it!

Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. - PubMed - NCBI

Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. - PubMed - NCBI | Mucosal Immunity | Scoop.it

Nature. 2016 Jan 14;529(7585):226-30. doi: 10.1038/nature16527. Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Gilbert C FAURE's insight:
Abstract

Helminth parasitic infections are a major global health and social burden. The host defence against helminths such as Nippostrongylus brasiliensis is orchestrated by type 2 cell-mediated immunity. Induction of type 2 cytokines, including interleukins (IL) IL-4 and IL-13, induce goblet cell hyperplasia with mucus production, ultimately resulting in worm expulsion. However, the mechanisms underlying the initiation of type 2 responses remain incompletely understood. Here we show that tuft cells, a rare epithelial cell type in the steady-state intestinal epithelium, are responsible for initiating type 2 responses to parasites by a cytokine-mediated cellular relay. Tuft cells have a Th2-related gene expression signature and we demonstrate that they undergo a rapid and extensive IL-4Rα-dependent amplification following infection with helminth parasites, owing to direct differentiation of epithelial crypt progenitor cells. We find that the Pou2f3 gene is essential for tuft cell specification. Pou2f3(-/-) mice lack intestinal tuft cells and have defective mucosal type 2 responses to helminth infection; goblet cell hyperplasia is abrogated and worm expulsion is compromised. Notably, IL-4Rα signalling is sufficient to induce expansion of the tuft cell lineage, and ectopic stimulation of this signalling cascade obviates the need for tuft cells in the epithelial cell remodelling of the intestine. Moreover, tuft cells secrete IL-25, thereby regulating type 2 immune responses. Our data reveal a novel function of intestinal epithelial tuft cells and demonstrate a cellular relay required for initiating mucosal type 2 immunity to helminth infection.

No comment yet.
Suggested by Société Francaise d'Immunologie
February 7, 2015 11:37 AM
Scoop.it!

Cutting Edge: The BTLA-HVEM Regulatory Pathway Interferes with Protective Immunity to Intestinal Helminth Infection [CUTTING EDGE]

Helminths exploit intrinsic regulatory pathways of the mammalian immune system to dampen the immune response directed against them.
No comment yet.
Scooped by Gilbert C FAURE
June 25, 2012 1:54 PM
Scoop.it!

Life, Health & Medicine: Nature Reviews Immunology Contents July ...

Life, Health & Medicine: Nature Reviews Immunology Contents July ... | Mucosal Immunity | Scoop.it
Epithelial cells mediate immunity to helminths by promoting type 2 innate effector cell responses. PDF Mucosal immunology: Don't forget our fungal friends p476 | doi:10.1038/nri3252. Dectin 1 mediates the immune response ...
No comment yet.